(Q34135330)

31 July 2017

1 reference

title

Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation (English)

1 reference

31 July 2017

1 reference

Goulden N

1

1 reference

31 July 2017

Oakhill A

series ordinal

2

1 reference

31 July 2017

Steward C

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

British Journal of Haematology

31 July 2017

published in

1 reference

31 July 2017

volume

112

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

275-281

1 reference

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Detection of minimal residual disease in acute leukemia by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Advances in therapy for childhood non-B-lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Immunophenotypical detection of minimal residual disease in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02560.X

10.1046/J.1365-2141.2001.02560.X

21 January 2018

Identifiers

DOI

1 reference

release_3dvujjrfc5btnkncagt2z3gxs4

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3dvujjrfc5btnkncagt2z3gxs4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference